ZEMURON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zemuron, and what generic alternatives are available?
Zemuron is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in ZEMURON is rocuronium bromide. There are eleven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the rocuronium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zemuron
A generic version of ZEMURON was approved as rocuronium bromide by HOSPIRA on November 26th, 2008.
Summary for ZEMURON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Clinical Trials: | 17 |
Patent Applications: | 1,094 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ZEMURON at DailyMed |
Recent Clinical Trials for ZEMURON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Rijeka | N/A |
McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
McGill University Health Center | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for ZEMURON
US Patents and Regulatory Information for ZEMURON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-001 | Mar 17, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-002 | Mar 17, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-003 | Mar 17, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZEMURON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-003 | Mar 17, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-001 | Mar 17, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-002 | Mar 17, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZEMURON
See the table below for patents covering ZEMURON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 608313 | ⤷ Try a Trial | |
South Korea | 0130208 | ⤷ Try a Trial | |
Hungary | 198738 | PROCESS FOR PRODUCING NEW 2BETA-MORPHOLINO-ANDROSTANE DERIVATIVES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZEMURON
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0287150 | 96C0038 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ROCURONIUMBROMIDE; NAT. REGISTRATION NO/DATE: 63 IS 9 F 12 19960709; FIRST REGISTRATION: NL RVG 16946 19940406 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |